$59B Quiet Shift Reshaping How Patients Access Care
The global point-of-care diagnostics market has reached $58.76 billion in 2026, growing nearly 10% annually. Investors are increasingly favoring digital health startups over traditional drug discovery, with companies like VentriPoint Diagnostics at the forefront, showcasing AI-powered solutions at major conferences. The market is projected to expand to $114.65 billion by 2035, driven by innovations in technology.
Issued on behalf of VentriPoint Diagnostics Ltd. Equity-Insider.com News Commentary VANCOUVER, BC, May 12, 2026 /PRNewswire/ — Point-of-care diagnostics just crossed $58.76 billion globally in 2026, growing at nearly 10% annually as testing that used to require a hospital lab now fits on…